Sources and docs: Midwest nonprofit Veritas Society used geofenced data to serve abortion clinic visitors anti-abortion ads on Facebook, Instagram, and Snapchat
Context & Ripple Effects
This is not a new tactic being exposed but an old one finally documented from the inside: reporting goes back to [[a:870120|2016, when anti-abortion groups were already using smartphone geo-fencing to serve ads to women inside clinics]], and the WSJ's sources and internal documents now confirm the pipeline ran through mainstream platforms — Facebook, Instagram, and Snapchat — rather than obscure ad networks.
The timing sharpens it. After the draft ruling reversing Roe, broker Tapestri reported companies asking to buy device-level clinic visit data [[a:981602]], prompting SafeGraph to stop selling family-planning center location data altogether, and the FTC sued Kochava over exactly this category of sensitive-location resale. Veritas Society shows the demand side never went away — it moved onto the big platforms' own ad systems.
First-order effects
- Meta and Snap now face direct questions about why their ad systems accepted geofenced clinic-visitor targeting from a single Midwest nonprofit, putting their location-based ad segments under the same scrutiny the FTC has applied to brokers.
- Veritas Society's method is no longer inferred from ad patterns but evidenced by documents, making it the concrete named case regulators and platform trust teams can act on.
Second-order effects
- Brokers still selling reproductive-health location data — the segment where SafeGraph exited and Kochava is already facing an FTC lawsuit — should expect the enforcement perimeter to widen from resale to the advertising buyers who operationalize it.
- Advertisers and advocacy groups using geofencing as a legitimate retail or outreach tool face tighter platform restrictions on location-based audiences, since Meta and Snap can most easily cut the whole capability rather than audit each buyer.
Third-order effects
- If platforms follow the FTC's lead, sensitive-location ad targeting gets carved out of self-serve ad systems entirely, pushing clinic-adjacent targeting into less transparent channels and shifting the battleground from brokers to whoever audits the buy side.
- The seven-year arc — 2016 tactic, post-Roe broker demand, FTC action against Kochava, now documented platform delivery — points toward reproductive-health location data becoming a formally regulated data category rather than one policed case by case.
The trend: Geofenced targeting of abortion clinic visitors is moving from a niche broker tactic toward a platform-enforcement and regulatory flashpoint, with the FTC's Kochava case setting the template.